114 related articles for article (PubMed ID: 37650761)
1. Differential survival of Brazilian patients with diffuse large B-cell lymphoma with and without HIV infection.
Ferreira MP; Thuler LCS; Bergmann A; Soares EA; Soares MA
AIDS; 2023 Dec; 37(15):2331-2338. PubMed ID: 37650761
[TBL] [Abstract][Full Text] [Related]
2. [Clinical characteristics and prognostic features of 63 HIV-associated diffuse large B-cell lymphoma: a single-center real-world study in China].
Wang CY; Liu J; Liang XP; Guo BL; Hu RZ; Liu Y
Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):203-208. PubMed ID: 35405777
[No Abstract] [Full Text] [Related]
3. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
Jaime-Pérez JC; Gamboa-Alonso CM; Vázquez-Mellado de Larracoechea A; Rodríguez-Martínez M; Gutiérrez-Aguirre CH; Marfil-Rivera LJ; Gómez-Almaguer D
Arch Med Res; 2015 Aug; 46(6):454-61. PubMed ID: 26235285
[TBL] [Abstract][Full Text] [Related]
4. Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era.
Besson C; Lancar R; Prevot S; Algarte-Genin M; Delobel P; Bonnet F; Meyohas MC; Partisani M; Oberic L; Gabarre J; Goujard C; Boue F; Coppo P; Costello R; Hendel-Chavez H; Mekerri N; Dos Santos G; Recher C; Delarue R; Casasnovas RO; Taoufik Y; Mounier N; Costagliola D;
AIDS; 2017 Nov; 31(18):2493-2501. PubMed ID: 28926410
[TBL] [Abstract][Full Text] [Related]
5. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
[TBL] [Abstract][Full Text] [Related]
6. Association of KIR Genes Polymorphism and its HLA Ligands in Diffuse Large B-cell Lymphoma.
Daniela Maira C; Amanda Vansan M; Fernando G; Silvia M; Sofia L; Márcia D; Francisco José Penteado A; Jeane Eliete Laguila V; Cármino Antonio S
Clin Lymphoma Myeloma Leuk; 2023 Jun; 23(6):438-445. PubMed ID: 37105848
[TBL] [Abstract][Full Text] [Related]
7. CD20-negative de novo diffuse large B-cell lymphoma in HIV-negative patients: a matched case-control analysis in a single institution.
Li YJ; Li ZM; Rao HL; Xia Y; Huang HQ; Xia ZJ; Li S; Li WY; Jiang WQ
J Transl Med; 2012 May; 10():84. PubMed ID: 22554077
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with survival in patients with lymphoma and HIV.
Vargas JC; Marques MO; Pereira J; Braga WMT; Hamerschlak N; Tabacof J; Ferreira PRA; Colleoni GWB; Baiocchi OCG
AIDS; 2023 Jul; 37(8):1217-1226. PubMed ID: 36939075
[TBL] [Abstract][Full Text] [Related]
9. Large cell lymphoma: correlation of HIV status and prognosis with differentiation profiles assessed by immunophenotyping.
Pather S; Mohamed Z; McLeod H; Pillay K
Pathol Oncol Res; 2013 Oct; 19(4):695-705. PubMed ID: 23670212
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of human immunodeficiency virus-associated Burkitt lymphoma and diffuse large B-cell lymphoma treated in Australia: A report from the Australasian Lymphoma Alliance.
Lim KJC; Di Ciaccio P; Polizzotto MN; Milliken S; Cochrane T; Goh Z; Shaw B; Perry E; Gilbertson M; Kermode W; Cheah CY; Latimer M; Hamad N; Ku M
Br J Haematol; 2023 Jun; 201(5):865-873. PubMed ID: 36866733
[TBL] [Abstract][Full Text] [Related]
11. The prognostic impact of monocyte fluorescence, immunosuppressive monocytes and peripheral blood immune cell numbers in HIV-associated Diffuse Large B-cell Lymphoma.
Vaughan J; Wiggill T; Lawrie D; Machaba M; Patel M
PLoS One; 2023; 18(1):e0280044. PubMed ID: 36630466
[TBL] [Abstract][Full Text] [Related]
12. Contributions of HIV to Non-Hodgkin Lymphoma Mortality Trends in the United States.
Howlader N; Shiels MS; Mariotto AB; Engels EA
Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1289-96. PubMed ID: 27418269
[TBL] [Abstract][Full Text] [Related]
13. HIV Infection and Survival of Lymphoma Patients in the Era of Highly Active Antiretroviral Therapy.
Han X; Jemal A; Hulland E; Simard EP; Nastoupil L; Ward E; Flowers CR
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):303-311. PubMed ID: 27756777
[No Abstract] [Full Text] [Related]
14. Predictors of survival after a diagnosis of non-Hodgkin lymphoma in a resource-limited setting: a retrospective study on the impact of HIV infection and its treatment.
Bateganya MH; Stanaway J; Brentlinger PE; Magaret AS; Wald A; Orem J; Casper C
J Acquir Immune Defic Syndr; 2011 Apr; 56(4):312-9. PubMed ID: 21350364
[TBL] [Abstract][Full Text] [Related]
15. Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin's lymphoma.
Lurain K; Ramaswami R; Mangusan R; Widell A; Ekwede I; George J; Ambinder R; Cheever M; Gulley JL; Goncalves PH; Wang HW; Uldrick TS; Yarchoan R
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33608378
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
17. [The prognostic impact of diabetic mellitus and hyperglycemia during DLBCL treatment on patients with diffuse large B-cell lymphoma].
Hu Y; Xu YJ; Li MZ; Lan YX; Mao L; Ning QY; Xu W; Yang HL; Zhang YZ
Zhonghua Xue Ye Xue Za Zhi; 2021 Feb; 42(2):151-157. PubMed ID: 33858047
[No Abstract] [Full Text] [Related]
18. HIV-infection impact on clinical-biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era.
Baptista MJ; Garcia O; Morgades M; Gonzalez-Barca E; Miralles P; Lopez-Guillermo A; Abella E; Moreno M; Sancho JM; Feliu E; Ribera JM; Navarro JT
AIDS; 2015 Apr; 29(7):811-8. PubMed ID: 25730510
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression profile and prognosis in patients with diffuse large B-cell lymphoma with or without human immunodeficiency virus infection.
Xicoy B; Ribera JM; Mate JL; Tapia G; Morgades M; Navarro JT; Sanz C; Ariza A; Feliu E
Leuk Lymphoma; 2010 Nov; 51(11):2063-9. PubMed ID: 20929323
[TBL] [Abstract][Full Text] [Related]
20. Cytokine profiles in patients with newly diagnosed diffuse large B-cell lymphoma: IL-6 and IL-10 levels are associated with adverse clinical features and poor outcomes.
Bao C; Gu J; Huang X; You L; Zhou Z; Jin J
Cytokine; 2023 Sep; 169():156289. PubMed ID: 37453327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
